OQROGet OQRO Pro
Insider trade

Usana Health Sciences (USNA)Director sold ~$35K

John Turman Fleming, Director at Usana Health Sciences, sold ~$35K of Usana Health Sciences shares.

~$35K
Approx. value · 1,750 sh @ $19.79
4,565
Holds after · shares reported
Traded
Oct 31, 2025
Filed
Nov 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 9, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Oct 22, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Oct 31, 2025 · this disclosureInsiderDirector sold ~$35K of USNA shares in the open market

What came next

  1. Nov 3, 2025InsiderDirector sold ~$23K of USNA shares in the open market
  2. Nov 10, 2025InsiderDirector sold ~$38K of USNA shares in the open market
  3. Dec 10, 2025Insider · 2 peopleInsiders: 2 sales (~$74K)
  4. Jan 8, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 8, 2026, USANA Health Sciences, Inc. (the “Company” or “USANA”) announced a leadership transition pursuant to which Jim Brown stepped down as Chief Executive Officer and President of the Company.”
  5. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  6. Feb 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 5, 2026, the Company and Mr. Brown entered into a Transition Agreement (the “Transition Agreement”) which documents his transition from the Company’s Chief Executive Officer and President to a strategic advisor to Mr. Guest and the Company from January 7, 2026, through December 31, 2026 (the “Transition Period”).”
  7. Feb 17, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  8. Feb 20, 2026InsiderOfficer sold ~$95K of USNA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Usana Health Sciences

OQRO holds no insider, Congress, fund or contract record for Usana Health Sciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its USNA page.

Other recent filings by John Turman Fleming, Director

The full history of John Turman Fleming, Director is on the profile page.

How this filing works

Other disclosures at Usana Health Sciences

Everything OQRO holds on this company is on its USNA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data